IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Call: Sarepta Therapeutics NOV 155 EXP 11/16/18

CUSIP: 8036086SK | 1 institutional holders

Quarters

Q3 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile